Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion

American Journal of Ophthalmology

Volumn 136, Issue 3, 2003, Pages 419-425

  Park, Carl H ^a   Jaffe, Glenn J ^a   Fekrat, Sharon ^a,b  

^a DUKE UNIVERSITY EYE CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRIAMCINOLONE ACETONIDE;

ADULT; AGED; AQUEOUS SOLUTION; ARTICLE; CENTRAL RETINA VEIN OCCLUSION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; EYE; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; GENERAL CONDITION IMPROVEMENT; GLAUCOMA; HUMAN; INJECTION; INTRAOCULAR PRESSURE; INTRAOCULAR PRESSURE ABNORMALITY; MALE; MEASUREMENT; MICROSCOPIC ANATOMY; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; RETINA MACULA CYSTOID EDEMA; STATISTICAL SIGNIFICANCE; TOMOGRAPHY; TRABECULECTOMY; VISUAL ACUITY; VITREOUS BODY; VOLUMETRY;

EID: 0041826878     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(03)00228-9     Document Type: Article

References (12)

1. Evaluation of grid laser pattern photocoagulation for macular edema in central vein occlusion. Ophthalmology. 102:1995;1425-1433.
2. Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol. 115:1997;486-491.
3. Greenberg P.B., Martidis A., Rogers A.H., Duker J.S., Reichel E. Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Br J Ophthalmol. 86:2002;247-248.
4. McCuen B.W., Bressler M., Tano Y., Chandler D., Machemer R. The lack of toxicity of intravitreal administered triamcinolone acetonide. Am J Ophthalmol. 91:1981;785-788.
5. Danis R.P., Ciulla T.A., Pratt L.M., Anliker W. Intravitreal triamcinolone acetonide in exudative age related macular degeneration. Retina. 20:2000;244-250.
6. Antcliff R.J., Spalton, D.J., Stanford M.R., Graham E.M., Ffytche T.J., Marshall J. Intravitreal triamcinolone for uveitic cystoid macular edema an optical coherence tomography study . Ophthalmology. 108:2001;765-772.
7. Jonas J.B., Sofker A. Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophthalmol. 132:2001;425-427.
8. Hida T., Chandler D., Arena J.E., Machemer R. Experimental and clinical observations of the intraocular toxicity of commercial corticosteroid preparations. Am J Ophthalmol. 101:1986;190-195.
9. Kitazawa Y., Horie T. The prognosis of corticosteroid-responsive individuals. Arch Ophthalmol. 99:1981;819-823.
10. Martidis A., Duker J.S., Greenberg P.B., Rogers A.H., Puliafito C.A., Reichel E., Baumal C. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology. 109:2002;920-927.
11. Schindler R.H., Chandler D., Thresher R., Machemer R. The clearance of intravitreal triamcinolone acetonide. Am J Ophthalmol. 93:1982;415-417.
12. Jaffe G.J., Ben-Nun J., Guo H., Dunn J.P., Ashton P. Fluocinolone acetonide sustained drug delivery to treat severe uveitis. Ophthalmology. 107:2000;2024-2033.